Skip to main content
Government Resource

Assessing the National Electronic Injury Surveillance System—Cooperative Adverse Drug Event Surveillance Project—six sites, United States, January 1–June 15, 2004.

Prevention C for DC and. Assessing the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project--six sites, United States, January 1-June 15, 2004. MMWR Morb Mortal Wkly Rep. 2005;54(15):380-3.

Save
Print
May 4, 2005
Prevention C for DC and. MMWR Morb Mortal Wkly Rep. 2005;54(15):380-3.

The Centers for Disease Control (CDC), the Consumer Product Safety Commission (CPSC), and the Food and Drug Administration (FDA) collaboratively created this surveillance project to estimate incidence of adverse drug events. The summary describes the evaluation of the system, based on studying reports from a convenience sample of participating hospitals. While the sensitivity of capturing events was low, the positive predictive value that reported events represented in actual cases was high. An editorial note suggests that this reporting system may represent an important, ongoing resource for recording and preventing future adverse drug events.

Save
Print
Cite
Citation

Prevention C for DC and. Assessing the National Electronic Injury Surveillance System-Cooperative Adverse Drug Event Surveillance project--six sites, United States, January 1-June 15, 2004. MMWR Morb Mortal Wkly Rep. 2005;54(15):380-3.